Monte Rosa Therapeutics, Inc.

GLUE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$15.38-6.90%

2026-08-03

Financials

Valuation Metrics

Monte Rosa Therapeutics, Inc.'s Market Cap is $1.30B. At end of 2025 it was $1.03B. Ranked #2281 of 3,111 in US market (top 73%), #911 of 1,445 on NASDAQ (top 63%), #170 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 63%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.30B	US#2,281/3,111 Sec#170/269
Revenue	$43M	US#2,876/3,111 Sec#161/269
Net Income	$-130M	US—/3,111 Sec—/269
Total Assets	$736M	US#2,585/3,111 Sec#121/269
Net Assets	$522M	US#2,229/3,111 Sec#111/269
Value
P/B	2.49x	US#1,558/3,111 Sec#78/269
P/S	30.25x	US#2,863/3,111 Sec#162/269
FCF Yield	-1.51%	US—/3,111 Sec—/269
Profitability
ROE	-24.91%	US#2,578/3,111 Sec#116/269
ROA	-17.65%	US#2,763/3,111 Sec#120/269
Op. Margin	-345.21%	US#2,890/3,111 Sec#157/269
Revenue Growth	-95.04%	US#2,944/3,111 Sec#184/269
Earnings Growth	-194.92%	US#2,225/3,111 Sec#82/269
Financial Health
Debt Ratio	41.10%	US#470/3,111 Sec#131/269
Total Debt	$39M	US#2,624/3,111 Sec#158/269
FCF	$-20M	US#2,382/3,111 Sec#93/269
Cash	$160M	US#1,895/3,111 Sec#140/269
Current Ratio	9.54x	US#256/3,111 Sec#84/269
Performance
1Y Return	221.09%	US#74/3,111 Sec#26/269
1M Return	-36.47%	US#3,028/3,111 Sec#260/269
From 52W High	-40.32%	US#2,333/3,111 Sec#181/269
1Y MDD	-41.84%	US#2,032/3,111 Sec#150/269
Trading
Volume	2,314,560 shares	US#221/3,111 Sec#15/269
Trading Value	$37M	US#792/3,111 Sec#46/269
Per Share
EPS	$-0.59	US—/3,111 Sec—/269
BPS	$3.56	US#2,369/3,111 Sec#154/269